Cargando…
Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know
Hypercholesterolemia is a risk factor for carotid artery stenosis and stroke. Statins are the main drugs for the management of hypercholesterolemia and they are strongly recommended by international guidelines for the management of vascular patients. The present review will focus on the associations...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607102/ https://www.ncbi.nlm.nih.gov/pubmed/33178797 http://dx.doi.org/10.21037/atm.2020.02.176 |
_version_ | 1783604576452083712 |
---|---|
author | Paraskevas, Kosmas I. Veith, Frank J. Eckstein, Hans-Henning Ricco, Jean-Baptiste Mikhailidis, Dimitri P. |
author_facet | Paraskevas, Kosmas I. Veith, Frank J. Eckstein, Hans-Henning Ricco, Jean-Baptiste Mikhailidis, Dimitri P. |
author_sort | Paraskevas, Kosmas I. |
collection | PubMed |
description | Hypercholesterolemia is a risk factor for carotid artery stenosis and stroke. Statins are the main drugs for the management of hypercholesterolemia and they are strongly recommended by international guidelines for the management of vascular patients. The present review will focus on the associations between cholesterol, carotid artery stenosis and stroke and will cover several topics, including the conservative and perioperative/periprocedural management of carotid patients, the effect of statins on contrast-induced nephropathy developing after endovascular carotid interventions, the role of statin loading prior to endovascular procedures, as well as the indirect beneficial effects of statin treatment on renal function. It will also discuss the topics of statin intolerance and alternative cholesterol-lowering options for statin-intolerant vascular patients. Cholesterol levels play a prognostic role in carotid patients with regards to both short- and long-term stroke and mortality rates. Physicians should keep in mind the pivotal role of cholesterol levels in determining cardiovascular outcomes and the pleiotropic beneficial effects associated with statin use and should not miss the opportunity for cardiovascular risk reduction with aggressive statin treatment. |
format | Online Article Text |
id | pubmed-7607102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-76071022020-11-10 Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know Paraskevas, Kosmas I. Veith, Frank J. Eckstein, Hans-Henning Ricco, Jean-Baptiste Mikhailidis, Dimitri P. Ann Transl Med Review Article on Carotid Artery Stenosis and Stroke: Prevention and Treatment Part I Hypercholesterolemia is a risk factor for carotid artery stenosis and stroke. Statins are the main drugs for the management of hypercholesterolemia and they are strongly recommended by international guidelines for the management of vascular patients. The present review will focus on the associations between cholesterol, carotid artery stenosis and stroke and will cover several topics, including the conservative and perioperative/periprocedural management of carotid patients, the effect of statins on contrast-induced nephropathy developing after endovascular carotid interventions, the role of statin loading prior to endovascular procedures, as well as the indirect beneficial effects of statin treatment on renal function. It will also discuss the topics of statin intolerance and alternative cholesterol-lowering options for statin-intolerant vascular patients. Cholesterol levels play a prognostic role in carotid patients with regards to both short- and long-term stroke and mortality rates. Physicians should keep in mind the pivotal role of cholesterol levels in determining cardiovascular outcomes and the pleiotropic beneficial effects associated with statin use and should not miss the opportunity for cardiovascular risk reduction with aggressive statin treatment. AME Publishing Company 2020-10 /pmc/articles/PMC7607102/ /pubmed/33178797 http://dx.doi.org/10.21037/atm.2020.02.176 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Review Article on Carotid Artery Stenosis and Stroke: Prevention and Treatment Part I Paraskevas, Kosmas I. Veith, Frank J. Eckstein, Hans-Henning Ricco, Jean-Baptiste Mikhailidis, Dimitri P. Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know |
title | Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know |
title_full | Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know |
title_fullStr | Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know |
title_full_unstemmed | Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know |
title_short | Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know |
title_sort | cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know |
topic | Review Article on Carotid Artery Stenosis and Stroke: Prevention and Treatment Part I |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607102/ https://www.ncbi.nlm.nih.gov/pubmed/33178797 http://dx.doi.org/10.21037/atm.2020.02.176 |
work_keys_str_mv | AT paraskevaskosmasi cholesterolcarotidarterydiseaseandstrokewhatthevascularspecialistneedstoknow AT veithfrankj cholesterolcarotidarterydiseaseandstrokewhatthevascularspecialistneedstoknow AT ecksteinhanshenning cholesterolcarotidarterydiseaseandstrokewhatthevascularspecialistneedstoknow AT riccojeanbaptiste cholesterolcarotidarterydiseaseandstrokewhatthevascularspecialistneedstoknow AT mikhailidisdimitrip cholesterolcarotidarterydiseaseandstrokewhatthevascularspecialistneedstoknow |